{
    "nct_id": "NCT04459416",
    "official_title": "Opioid-Sparing Pain Treatment In Myeloma And Lymphoma Patients Undergoing High-Dose Chemotherapy (OPTIMAL-HiChemo): Randomized Controlled Trial",
    "inclusion_criteria": "* age 18 or older\n* pathological diagnosis of MM, HD or NHL\n* scheduled for high dose chemotherapy for auto-HSCT in the following month (30 days)\n* not taking opioids regularly in the week prior to consent (one-time dosing of opioids for a painful procedure is allowed)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* absolute neutrophil count (ANC) of <500/μl, platelet count of <20,000/ μl or INR >2.0\n* acupuncture within two weeks prior to HiChemo (to avoid residual effects of acupuncture)\n* unable to provide informed consent",
    "miscellaneous_criteria": ""
}